BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7686090)

  • 1. In vivo T cell depletion in rheumatoid arthritis is associated with increased in vitro IgM-rheumatoid factor synthesis.
    Olsen NJ; Teal GP; Strand V
    Clin Immunol Immunopathol; 1993 May; 67(2):124-9. PubMed ID: 7686090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.
    Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H
    Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis.
    Nonaka S; Yasuda M; Nobunaga M
    J Rheumatol; 1993 Sep; 20(9):1478-84. PubMed ID: 7513025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.
    Olsen N; Ziff M; Jasin HE
    Rheumatol Int; 1982; 2(2):59-66. PubMed ID: 6983711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective induction of IgM rheumatoid factors by CD14+ monocyte-lineage cells generated from bone marrow of patients with rheumatoid arthritis.
    Hirohata S; Yanagida T; Koda M; Koiwa M; Yoshino S; Ochi T
    Arthritis Rheum; 1995 Mar; 38(3):384-8. PubMed ID: 7880194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis.
    Koopman WJ; Schrohenloher RE
    Arthritis Rheum; 1980 Sep; 23(9):985-92. PubMed ID: 6968215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.
    Keogan MT; Callaghan M; Yanni G; Mulherin D; Feighery C; Brown DL; Fitzgerald MX; Bresnihan B
    Clin Exp Immunol; 1993 Mar; 91(3):462-6. PubMed ID: 7680296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.
    Jasin HE
    Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of in vitro IgM rheumatoid factor synthesis correlate with HLA-DR4 in normal individuals.
    Olsen NJ; Stastny P; Jasin HE
    Arthritis Rheum; 1987 Aug; 30(8):841-8. PubMed ID: 3498492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis.
    Xu H; Geddes R; Roberts-Thomson PJ
    Ann Rheum Dis; 1994 Jun; 53(6):383-90. PubMed ID: 7518662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves' disease.
    Jones BM; Cheng IK; Wong RW; Kung AW
    Scand J Immunol; 1993 Dec; 38(6):575-80. PubMed ID: 7504827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune function in severe, active rheumatoid arthritis.
    Boling EP; Ohishi T; Wahl SM; Misiti J; Wistar R; Wilder RL
    Clin Immunol Immunopathol; 1987 May; 43(2):185-94. PubMed ID: 3552341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity.
    Jarvis JN; Kaplan J; Fine N
    Arthritis Rheum; 1992 Feb; 35(2):204-7. PubMed ID: 1370899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 modulation of rheumatoid factor synthesis.
    Alvarellos A; Lipsky PE; Jasin HE
    Arthritis Rheum; 1988 Dec; 31(12):1473-80. PubMed ID: 3264162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia.
    Meroni PL; Barcellini W; Sinico RA; Fornasieri A; Sguotti C; Invernizzi F; D'Amico G; Zanussi C
    Clin Exp Immunol; 1986 Aug; 65(2):303-10. PubMed ID: 3491708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
    Jones BM; Cheng IK; Wong RW
    Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased T-cell-mediated suppression of IgM--rheumatoid factor synthesis in rheumatoid arthritis.
    Olsen NJ; Jasin HE
    Clin Immunol Immunopathol; 1987 Jan; 42(1):38-49. PubMed ID: 2947767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alpha-interferon enhances in vitro IgM rheumatoid factor synthesis by lymphocytes from normal subjects and rheumatoid arthritis patients.
    Rodriguez MA; Prinz WA; Sibbitt WL; Bankhurst AD; Williams RC
    Arthritis Rheum; 1983 Sep; 26(9):1091-7. PubMed ID: 6311224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro.
    Ceuppens JL; Rodriguez MA; Goodwin JS
    Lancet; 1982 Mar; 1(8271):528-30. PubMed ID: 6120390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.